Induction Chemotherapy for Locally Recurrent Rectal Cancer
Conditions
Recurrent Rectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UZ Gent, Ghent, Belgium
Contact: Study coordinator (Gabrielle van Ramshorst, MD, PhD)Amsterdam UMC, Amsterdam, Netherlands
Contact: Study coordinator (Miranda Kusters, MD, PhD)Antoni van Leeuwenhoek, Amsterdam, Netherlands
Contact: Study coordinator (Arend Aalbers, MD, PhD)Catharina Hospital, Eindhoven, Netherlands
University Medical Centre Groningen, Groningen, Netherlands
Contact: Study coordinator (Klaas Havenga, MD, PhD)Leids University Medical Centre, Leiden, Netherlands
Contact: Study coordinator (Fabian Holman, Md, PhD)Haaglanden Medical Centre, Leidschendam, Netherlands
Contact: Study coordinator (Andreas Marinelli, MD, PhD)Maastricht University Medical Centre, Maastricht, Netherlands
Contact: Study coordinator (Jarno Melenhorst, MD, PhD)Erasmus Medical Centre, Rotterdam, Netherlands
Contact: Study coordinator (Cornelis Verhoef, MD, PhD)Oslo Universitetssykehus, Oslo, Norway
Contact: Study coordinator (Marianne Guren, MD, PhD)Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon, Portugal
Contact: Study coordinator (João Maciel, MD, PhD)Sahlgrenska Universitetssjukhuset, Gothenburg, Sweden
Contact: Study coordinator (Eva Angenete, MD, PhD)Contact: Study coordinator (Sofia Heyman, MD, PhD)Skåne Universitetssjukhuset, Malmö, Sweden
Contact: Study coordinator (Pamela Buchwald, MD, PhD)Karolinska Universitetssjukhuset, Stockholm, Sweden
Contact: Study coordinator (Henrik Iversen, MD, PhD)
Study leads
Pim Burger, MD
Principal Investigator
Catharina Ziekenhuis Eindhoven